Pharmacogenetics-expectations and reality - Drug response and toxicity depend on genes, environment, and behaviour

[1] [Anonymous], STRENGTH CLIN RES

[2] FDA, 2004, INN STAGN CHALL OPP

[3] Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 91 (01) : 87 - 94

[4] Hapgood R, 2003, BRIT J GEN PRACT, V53, P915

[5] Genetic variations in HLA-B region and hypersensitivity reactions to abacavir [J]. LANCET, 2002, 359 (9312) : 1121 - 1122

[6] Lee Sandra Soo-Jin, 2003, Am J Pharmacogenomics, V3, P385, DOI 10.2165/00129785-200303060-00005

[7] Smith SE, 1973, VARIABILITY HUMAN DR

[8] The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) : 212 - 220

[9] Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.

[10] Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719

[1] [Anonymous], STRENGTH CLIN RES

[2] FDA, 2004, INN STAGN CHALL OPP

[3] Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 91 (01) : 87 - 94

[4] Hapgood R, 2003, BRIT J GEN PRACT, V53, P915

[5] Genetic variations in HLA-B region and hypersensitivity reactions to abacavir [J]. LANCET, 2002, 359 (9312) : 1121 - 1122

[6] Lee Sandra Soo-Jin, 2003, Am J Pharmacogenomics, V3, P385, DOI 10.2165/00129785-200303060-00005

[7] Smith SE, 1973, VARIABILITY HUMAN DR

[8] The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) : 212 - 220

[9] Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.

[10] Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719